Imperial College London

DrJonathanKrell

Faculty of MedicineDepartment of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Giannone:2022:10.1016/j.annonc.2022.04.022,
author = {Giannone, G and Ennis, D and Mirza, HB and Cheng, Z and McDermott, J and Lewsley, L-A and Clamp, AR and Herbertson, RA and Glasspool, RM and Krell, J and Hinsley, S and Banerji, U and Riisnaes, R and Banerjee, S and McNeish, I},
doi = {10.1016/j.annonc.2022.04.022},
pages = {S384--S384},
publisher = {ELSEVIER},
title = {Targeting PI3K/AKT/mTOR pathway in platinum-resistant ovarian high-grade serous carcinoma: Translational analysis from the randomized phase II OCTOPUS trial},
url = {http://dx.doi.org/10.1016/j.annonc.2022.04.022},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Giannone,G
AU - Ennis,D
AU - Mirza,HB
AU - Cheng,Z
AU - McDermott,J
AU - Lewsley,L-A
AU - Clamp,AR
AU - Herbertson,RA
AU - Glasspool,RM
AU - Krell,J
AU - Hinsley,S
AU - Banerji,U
AU - Riisnaes,R
AU - Banerjee,S
AU - McNeish,I
DO - 10.1016/j.annonc.2022.04.022
EP - 384
PB - ELSEVIER
PY - 2022///
SN - 0923-7534
SP - 384
TI - Targeting PI3K/AKT/mTOR pathway in platinum-resistant ovarian high-grade serous carcinoma: Translational analysis from the randomized phase II OCTOPUS trial
UR - http://dx.doi.org/10.1016/j.annonc.2022.04.022
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000814982500005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -